Advancing precision cancer medicine via European collaboration
Learn more about the EU-funded Norwegian initiatives PCM4EU and PRIME-ROSE, and the Norwegian MATRIX Centre. Two Norwegian EU-funded...
top of page
Norwegian Cancer Precision Medicine Implementation Consortium
Latest news
- Feb 28
- 3 min
Success criteria for industry-sponsored clinical trials
The third educational seminar in the clinical trials meeting series arranged by CONNECT Working Group 2 took place via Zoom on 13 February.
- Oct 31, 2022
- 5 min
CONNECT seminar: investigator-initiated clinical trials
How can researchers have successful collaborations with industry in clinical studies? This was a central question at a recent CONNECT semina
- Oct 18, 2022
- 1 min
Inclusion of clinical opinions in economic evaluations
How can clinicians be more involved in healthcare decision-making?
- Sep 26, 2022
- 4 min
Kicking off the Clinical Trials meeting series
Industry-sponsored clinical studies in Norway were in focus at the kick-off meeting for a new meeting series hosted by CONNECT Working Group
- Aug 31, 2022
- 4 min
The future of precision cancer medicine
The first national initiatives for precision cancer medicine have successfully taken shape in Norway, but what has been achieved and what do
- Jun 24, 2022
- 3 min
CONNECT grows to 30 partners
CONNECT welcomes the two new partners Gilead Sciences Nordic Region and the Norwegian Directorate for E-health.
- Jun 2, 2022
- 2 min
CONNECT seminar on Digital Pathology and AI
Experts from regional, national and international groups shared their perspectives on digital pathology and artificial intelligence (AI)...
- May 5, 2022
- 4 min
Norwegian cancer initiatives receive international attention
Norway is pioneering precision medicine in cancer with three nation-wide initiatives.
bottom of page